Search Results Search Sort by RelevanceMost Recent Health Law Dec 2016 The Legal Implications of Detecting Alzheimer’s Disease Earlier Joshua Preston, Jaleh McTeigue, Caitlin Opperman, Jordan Dean Scott Krieg, Mikaela Brandt-Fontaine, Alina Yasis, and Francis X. Shen, JD, PhD What are insurance, contract, and criminal law implications of detecting Alzheimer’s disease early? AMA J Ethics. 2016; 18(12):1207-1217. doi: 10.1001/journalofethics.2016.18.12.hlaw1-1612. Case and Commentary Feb 2021 临床医生应如何应对会加剧卫生不平等性的语言障碍? Jason Espinoza(医学博士) and Sabrina , Derrington(医学博士、文学硕士、已获认证的医疗保健伦理顾问) AMA J Ethics. 2021; E109-116. doi: 10.1001/amajethics.2021.109. Case and Commentary Feb 2021 ¿Cómo deberían responder los médicos clínicos a las barreras idiomáticas que exacerban la inequidad sanitaria? Jason Espinoza, MD and Sabrina Derrington, MD, MA, HEC-C AMA J Ethics. 2021; E109-116. doi: 10.1001/amajethics.2021.109. Case and Commentary Feb 2021 医生和药剂师应如何合作促进服务不足群体的卫生公平? Sara Shahdoost Moghadam(药学博士) and Sandra Leal(药学博士、公共卫生硕士、经认证的糖尿病护理和教育专家) AMA J Ethics. 2021; E117-126. doi: 10.1001/amajethics.2021.117. Case and Commentary Feb 2021 ¿Cómo deben colaborar los médicos y farmacéuticos para motivar la equidad sanitaria en las comunidades desatendidas? Sara Shahdoost Moghadam, PharmD and Sandra Leal, PharmD, MPH, CDCES AMA J Ethics. 2021; E117-126. doi: 10.1001/amajethics.2021.117. Case and Commentary Feb 2021 How Should Clinicians Respond to Language Barriers That Exacerbate Health Inequity? Jason Espinoza, MD and Sabrina Derrington, MD, MA, HEC-C Limited language proficiency is a driver of health inequity and exacerbates other social determinants of health. AMA J Ethics. 2021; 23(2):E109-116. doi: 10.1001/amajethics.2021.109. Case and Commentary Feb 2021 How Should Physicians and Pharmacists Collaborate to Motivate Health Equity in Underserved Communities? Sara Shahdoost Moghadam, PharmD and Sandra Leal, PharmD, MPH, CDCES Physicians and pharmacists play key roles in addressing social determinants of health and health inequity. AMA J Ethics. 2021; 23(2):E117-126. doi: 10.1001/amajethics.2021.117. Podcast Jul 2023 Author Interview: “Why We Need to Stop Labeling Behaviors Influencing a Person’s Weight Ideal or Healthy” Dr Madeline Ward joins Ethics Talk to discuss her article: “Why We Need to Stop Labeling Behaviors Influencing a Person’s Weight Ideal or Healthy." Case and Commentary Oct 2023 How to Draw on Narrative to Mitigate Ageism William Smith, MD, MBA, MPH, David Elkin, MD, MSL, and Art Walaszek, MD Ageism is so structurally integrated and normalized in US health care that it is generally unnoticed by many clinicians. AMA J Ethics. 2023; 25(10):E745-750. doi: 10.1001/amajethics.2023.745. Medicine and Society Oct 2023 What Might Aducanumab Teach Us About Clinicians’ Judgment About Whether to Recommend Emerging Alzheimer’s Interventions? Adam W. Burroughs, MD and Lewis P. Krain, MD Ethics questions about care of patients with AD could influence clinicians’ judgment about whether and when to recommend aducanumab. AMA J Ethics. 2023; 25(10):E777-782. doi: 10.1001/amajethics.2023.777. Pagination First page « First Previous page ‹ Previous … Page 2 Page 3 Page 4 Page 5 Current page 6 Page 7 Page 8 Page 9 Page 10 … Next page Next › Last page Last »
Health Law Dec 2016 The Legal Implications of Detecting Alzheimer’s Disease Earlier Joshua Preston, Jaleh McTeigue, Caitlin Opperman, Jordan Dean Scott Krieg, Mikaela Brandt-Fontaine, Alina Yasis, and Francis X. Shen, JD, PhD What are insurance, contract, and criminal law implications of detecting Alzheimer’s disease early? AMA J Ethics. 2016; 18(12):1207-1217. doi: 10.1001/journalofethics.2016.18.12.hlaw1-1612.
Case and Commentary Feb 2021 临床医生应如何应对会加剧卫生不平等性的语言障碍? Jason Espinoza(医学博士) and Sabrina , Derrington(医学博士、文学硕士、已获认证的医疗保健伦理顾问) AMA J Ethics. 2021; E109-116. doi: 10.1001/amajethics.2021.109.
Case and Commentary Feb 2021 ¿Cómo deberían responder los médicos clínicos a las barreras idiomáticas que exacerban la inequidad sanitaria? Jason Espinoza, MD and Sabrina Derrington, MD, MA, HEC-C AMA J Ethics. 2021; E109-116. doi: 10.1001/amajethics.2021.109.
Case and Commentary Feb 2021 医生和药剂师应如何合作促进服务不足群体的卫生公平? Sara Shahdoost Moghadam(药学博士) and Sandra Leal(药学博士、公共卫生硕士、经认证的糖尿病护理和教育专家) AMA J Ethics. 2021; E117-126. doi: 10.1001/amajethics.2021.117.
Case and Commentary Feb 2021 ¿Cómo deben colaborar los médicos y farmacéuticos para motivar la equidad sanitaria en las comunidades desatendidas? Sara Shahdoost Moghadam, PharmD and Sandra Leal, PharmD, MPH, CDCES AMA J Ethics. 2021; E117-126. doi: 10.1001/amajethics.2021.117.
Case and Commentary Feb 2021 How Should Clinicians Respond to Language Barriers That Exacerbate Health Inequity? Jason Espinoza, MD and Sabrina Derrington, MD, MA, HEC-C Limited language proficiency is a driver of health inequity and exacerbates other social determinants of health. AMA J Ethics. 2021; 23(2):E109-116. doi: 10.1001/amajethics.2021.109.
Case and Commentary Feb 2021 How Should Physicians and Pharmacists Collaborate to Motivate Health Equity in Underserved Communities? Sara Shahdoost Moghadam, PharmD and Sandra Leal, PharmD, MPH, CDCES Physicians and pharmacists play key roles in addressing social determinants of health and health inequity. AMA J Ethics. 2021; 23(2):E117-126. doi: 10.1001/amajethics.2021.117.
Podcast Jul 2023 Author Interview: “Why We Need to Stop Labeling Behaviors Influencing a Person’s Weight Ideal or Healthy” Dr Madeline Ward joins Ethics Talk to discuss her article: “Why We Need to Stop Labeling Behaviors Influencing a Person’s Weight Ideal or Healthy."
Case and Commentary Oct 2023 How to Draw on Narrative to Mitigate Ageism William Smith, MD, MBA, MPH, David Elkin, MD, MSL, and Art Walaszek, MD Ageism is so structurally integrated and normalized in US health care that it is generally unnoticed by many clinicians. AMA J Ethics. 2023; 25(10):E745-750. doi: 10.1001/amajethics.2023.745.
Medicine and Society Oct 2023 What Might Aducanumab Teach Us About Clinicians’ Judgment About Whether to Recommend Emerging Alzheimer’s Interventions? Adam W. Burroughs, MD and Lewis P. Krain, MD Ethics questions about care of patients with AD could influence clinicians’ judgment about whether and when to recommend aducanumab. AMA J Ethics. 2023; 25(10):E777-782. doi: 10.1001/amajethics.2023.777.